Project Number EUJPND-Belgium-FIE-JANSSEN PHARMACEUTICA-281 Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Year 2016 View Full Project Details for Biomarker based adaptive development in Alzheimer disease (BioAdaptAD) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator JANSSEN PHARMACEUTICA Principal Investigator First Name JANSSEN PHARMACEUTICA Principal Investigator Last Name JANSSEN PHARMACEUTICA Awardee Organization JANSSEN PHARMACEUTICA Contact PI Country Belgium Project Detail FY Overall Cost $560,320 Funding Organization Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Organization Country Belgium Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
